3323. Package # 370 (PCR. STI + HPV HCR)

Package № 370 ‘PCR, STI + HPV HCR’ is a set of studies required for suspected sexually transmitted infections: gonorrhea, trichomoniasis, chlamydia and mycoplasmas.

Clinical manifestations of these infections:

• mucopurulent discharge from the vagina or urethra;
• accompanied by an unpleasant odor;
• bleeding that occurs after intercourse or within the cycle in women;
• purulent discharge from the urethra;
• itching;
• urination disorders (dysuria);
• discomfort in the lower abdomen;
• pain during intercourse.

This screening is used:

• in pregnancy planning during pregnancy;
• for screening in high-risk groups (young people under 25 who do not have a regular sexual partner);
• for diagnosis in the presence of patient complaints and clinical symptoms of the infectious process;
• as a screening of patients whose sexual partners have these complaints or have been diagnosed with STIs, as well as to determine the presence of human papilloma virus of high carcinogenic risk (14 genotypes) as a major factor in the development of cervical cancer.

• to diagnose possible causes of inflammatory processes of the genitourinary system, their complications in women;
• to identify pathogens of specific infections: chlamydial infection, trichomoniasis, gonorrhea;
• for screening diagnosis of HPV genotypes of high carcinogenic risk;
• at preventive inspections; in chronic inflammatory diseases of the genitourinary system;
• in diagnosing the causes of infertility in women.

• Scrapes from various sites depending on the test

Women